Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Withdrawn 1Terminated 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 24Brain Neoplasms 19Neoplasm Metastasis 13Lung Neoplasms 13Pancreatic Neoplasms 11Melanoma 10Carcinoma, Renal Cell 9Carcinoma, Hepatocellular 9Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Prostatic Neoplasms 6Neoplasms 6Glioblastoma 6Breast Neoplasms 6Liver Neoplasms 5Head and Neck Neoplasms 4Glioma 3Colorectal Neoplasms 3Uveal Melanoma 2Sarcoma 2Mesothelioma 2Gliosarcoma 2Gastrointestinal Neoplasms 2Cholangiocarcinoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor 1Spinal Cord Compression 1Secondary Malignant Neoplasm of Liver 1Sarcoma, Ewing 1

Interventions

pembrolizumab 20atezolizumab 9Nivolumab 9Gemcitabine 9Docetaxel 5avelumab 4Mitomycin 4Carboplatin 4fludarabine 3epacadostat 3enfortumab vedotin 3Cyclophosphamide 3vofatamab 2valrubicin 2rucaparib 2pemigatinib 2durvalumab 2cabozantinib 2Standard of Care 2Sirolimus 2Radiation 2Pemetrexed 2Cisplatin 2Bevacizumab 2B701 protein, Human herpesvirus 6 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2trilaciclib 1temsirolimus 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Transitional Cell × Radiosurgery × Clear all
NCT04936230 2025-08-17

Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
1 enrolled 1 chart
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡